Table 2 GPX4 expression and clinical outcome of advanced RCC patients.

From: Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway

 

GPX4 mRNA expression

P

High (n = 40)

Low (n = 40)

OS

8.1

9.0

0.038

 

6.9–8.8 (M)

8.4–9.8 (M)

 
  1. OS overall survival.
Back to article page